Trans Genic Inc. (2342.T)
JPY 184.0
(-1.08%)
JPY 184.0
(-1.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.25 Billion JPY | -6.63% |
| 2022 | 2.41 Billion JPY | 32.79% |
| 2021 | 1.82 Billion JPY | -8.78% |
| 2020 | 1.99 Billion JPY | 13.52% |
| 2019 | 1.75 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.85 Billion JPY | 26.36% |
| 2023 Q1 | 2.41 Billion JPY | 0.03% |
| 2023 Q4 | 2.25 Billion JPY | -14.84% |
| 2023 Q3 | 2.65 Billion JPY | 9.45% |
| 2023 Q2 | 2.42 Billion JPY | 0.14% |
| 2023 FY | 2.25 Billion JPY | -6.63% |
| 2022 Q4 | 2.41 Billion JPY | -7.19% |
| 2022 FY | 2.41 Billion JPY | 32.79% |
| 2022 Q3 | 2.6 Billion JPY | 31.67% |
| 2022 Q2 | 1.97 Billion JPY | 0.0% |
| 2021 FY | 1.82 Billion JPY | -8.78% |
| 2020 FY | 1.99 Billion JPY | 13.52% |
| 2019 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 8.61% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 38.989% |
| Linical Co., Ltd. | 3 Billion JPY | 24.812% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -97735.284% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 8.686% |
| AnGes, Inc. | 362.67 Million JPY | -522.337% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2012.383% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 96.949% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -856.454% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -103.538% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -1133.562% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -155.0% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -513.802% |
| Chiome Bioscience Inc. | 291 Million JPY | -675.622% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 12.347% |
| PeptiDream Inc. | 22.79 Billion JPY | 90.101% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -616.14% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -239.408% |
| Healios K.K. | 4.53 Billion JPY | 50.197% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -1906.276% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -1479.988% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -2213.937% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -141.836% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -133.167% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -211.778% |
| StemCell Institute Inc. | 8.78 Million JPY | -25595.128% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -1392.271% |